# Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V

> **NCT07015931** · PHASE1,PHASE2 · COMPLETED · sponsor: **Indonesia University** · enrollment: 23 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** retinoic acid cream 0.025%
- **DRUG:** adapalene cream 0.1%

## Key facts

- **NCT ID:** NCT07015931
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-30
- **Primary completion:** 2025-03-08
- **Final completion:** 2025-03-15
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07015931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07015931, "Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07015931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*